Support. Don’t Punish. is a global grassroots campaign that calls for jurisdictions to implement drug policy that prioritises the health and wellbeing outcomes of people who use drugs and end cruel sanctions that target our community.
Το AIVL φιλοξένησε ένα διαδικτυακό φόρουμ για να συζητήσει και να διαμορφώσει ορισμένες από τις τοπικές και διεθνείς υπηρεσίες, συστήματα, υπεράσπιση και πολιτικές που εργάζονται για την προώθηση της υγείας, της ευημερίας και των ανθρωπίνων δικαιωμάτων των ατόμων που κάνουν χρήση ναρκωτικών.
Leah McLeod
AIVL & INPUD
Vice President of Australian Injecting and Illicit Drug Users League and Communications Specialist at International Network of People who Use Drugs
Presenting on the importance of supporting not punishing people who use drugs (PWUD) and the impacts of criminalisation on PWUD.
Juan Fernandez Ochoa
International Drug Policy Consortium
Campaigns and Communications Officer
Speaking about the Support Don’t Punish Campaign, decentralised initiatives to promote an end to the war on drugs, building sustainable alternatives emphasising full-spectrum harm reduction.
Paul Dessaur
Μείωση Βλάβης Βασισμένης σε Ομότιμους WA
Διευθύνων Σύμβουλος
Speaking on the importance of overdose response, increasing access of naloxone to police, and reflections upon whether this has shifted punitive attitude mindsets towards more supportive responses
Dr Kate Seear
Professor and Deputy Director of the Australian Research Centre in Sex, Health and Society, an Australian Research Council Future Fellow
Discussing the challenges and opportunities for drug law reform in Australia.
Lachlan Akers
Harm Reduction Coalition Aotearoa
Chair
Presenting on hauora outcomes for people who use drugs’ and striking a balance between the two extremes of prohibition and free market capitalism to achieve drug policy settings which best minimise harms associ...
Lachlan Akers
Harm Reduction Coalition Aotearoa
Chair
Presenting on hauora outcomes for people who use drugs’ and striking a balance between the two extremes of prohibition and free market capitalism to achieve drug policy settings which best minimise harms associated with the use of drugs.